Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
F 0.87 -1.89% -0.02
CVM closed down 1.89 percent on Friday, November 1, 2024, on 66 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.89%
NR7 Range Contraction -1.89%
Inside Day Range Contraction -1.89%
Down 3 Days in a Row Weakness -1.89%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 18 hours ago
Down 1% about 18 hours ago
New 52 Week Low about 18 hours ago
Up 1% about 21 hours ago
Possible NR7 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cel-Sci Corporation Description

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Immunology Immune System Immunotherapy Vaccines Autoimmunity Rheumatoid Arthritis Vaccination Transplantation Cytokine Head And Neck Cancer Antigen Immune Response Allergies

Is CVM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.23
52 Week Low 0.87
Average Volume 284,323
200-Day Moving Average 1.52
50-Day Moving Average 1.04
20-Day Moving Average 0.95
10-Day Moving Average 0.90
Average True Range 0.05
RSI (14) 30.56
ADX 28.28
+DI 9.63
-DI 21.37
Chandelier Exit (Long, 3 ATRs) 0.97
Chandelier Exit (Short, 3 ATRs) 1.01
Upper Bollinger Bands 1.07
Lower Bollinger Band 0.83
Percent B (%b) 0.17
BandWidth 25.07
MACD Line -0.05
MACD Signal Line -0.05
MACD Histogram -0.0012
Fundamentals Value
Market Cap 43.63 Million
Num Shares 50 Million
EPS -0.73
Price-to-Earnings (P/E) Ratio -1.20
Price-to-Sales 11797.42
Price-to-Book 9.30
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.94
Resistance 3 (R3) 0.95 0.93 0.93
Resistance 2 (R2) 0.93 0.92 0.93 0.93
Resistance 1 (R1) 0.90 0.90 0.90 0.90 0.92
Pivot Point 0.89 0.89 0.88 0.88 0.89
Support 1 (S1) 0.86 0.87 0.85 0.85 0.82
Support 2 (S2) 0.84 0.86 0.84 0.82
Support 3 (S3) 0.81 0.84 0.81
Support 4 (S4) 0.80